Tuesday, 10 Jun 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • House
  • White
  • VIDEO
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Colossal
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > Woman Dies After Using Weight-Loss Drug In U.K.’s First Case
Health and Wellness

Woman Dies After Using Weight-Loss Drug In U.K.’s First Case

Last updated: November 9, 2024 9:12 pm
Share
Woman Dies After Using Weight-Loss Drug In U.K.’s First Case
SHARE

A tragic incident has occurred in the U.K. involving a 58-year-old nurse named Susan McGowan who passed away after taking two doses of the weight-loss medication tirzepatide, also known as Mounjaro or Zepbound. According to reports, McGowan’s death was attributed to multiple organ failure, septic shock, and pancreatitis, with the Eli Lilly drug listed as a contributing factor on her death certificate.

McGowan had purchased the prescription for tirzepatide online and had taken two low doses of the drug over a period of two weeks. Shortly after her second dose, she began experiencing severe stomach pain and sickness, prompting her to seek treatment at University Hospital Monklands where she had worked for three decades. Unfortunately, her condition worsened, leading to kidney issues, coma, and eventually organ failure.

Tirzepatide is categorized as a GLP-1 receptor agonist, a class of weight-loss drugs that help reduce appetite by inducing a feeling of fullness. Similar to Novo Nordisk’s Ozempic, tirzepatide is known for its effectiveness in weight loss and managing type two diabetes. However, it is also associated with side effects such as vomiting, diarrhea, and nausea, and in rare cases, severe allergic reactions, kidney problems, stomach issues, and thyroid tumors.

Despite these risks, regulatory authorities maintain that the benefits of tirzepatide outweigh the potential drawbacks. The U.K.’s Medicines and Healthcare products Regulatory Authority approved the drug as a weight loss aid in 2023, closely monitoring adverse events through the Yellow Card reporting scheme. While a second death is under investigation for possible links to tirzepatide, no conclusive evidence has been established.

In response to the incident, Dr. Alison Cave, Chief Safety Officer at MHRA, emphasized the organization’s commitment to patient safety and the rigorous assessment of medicines before approval. Eli Lilly, the manufacturer of tirzepatide, also reiterated its dedication to monitoring and reporting safety information for all its products.

See also  Red and processed meat consumption associated with higher type 2 diabetes risk, study of 2 million people finds

As investigations continue into the circumstances surrounding Susan McGowan’s tragic death, it serves as a poignant reminder of the importance of patient safety and thorough evaluation of medication risks and benefits. Our thoughts are with McGowan’s family during this difficult time, and we hope that lessons learned from this incident will contribute to enhanced safety measures in the healthcare industry.

TAGGED:caseDiesDrugU.K.sWeightLossWoman
Share This Article
Twitter Email Copy Link Print
Previous Article Emilia Wickstead Resort 2025 Collection Emilia Wickstead Resort 2025 Collection
Next Article Days Before The Election Trump Melts Down Because He Isn’t Running Against Biden Days Before The Election Trump Melts Down Because He Isn’t Running Against Biden
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Cornell University MFA ’25 Presents Even the Phrase Each Other

Experience the Final Group Exhibition by Cornell University MFA Class of 2025 Don't miss out…

May 19, 2025

Victoria Beckham ‘Hopes To Use Teen Daughter Harper to Make Herself the Next Reality TV Momager’

Victoria Beckham Following in Kris Jenner's Footsteps to Turn Daughter Harper into a Star Victoria…

March 17, 2025

Trump Rally Speakers Rant About How New York Has Been Ruined

NEW YORK — At the recent Madison Square Garden rally hosted by former President Donald…

October 28, 2024

A Silver Lining, but… – Econlib

On April 2, President Donald Trump enacted a set of customs tariffs on imported goods…

April 4, 2025

Tim Walz has some sharp critiques of the Dem 2024 campaign

Tim Walz, the Minnesota governor who ran as Kamala Harris' vice presidential pick in the…

March 8, 2025

You Might Also Like

‘Day of the Jackal’ author Frederick Forsyth dies
World News

‘Day of the Jackal’ author Frederick Forsyth dies

June 10, 2025
Yale LISTEN Study participants want to be heard, not politicized
Health and Wellness

Yale LISTEN Study participants want to be heard, not politicized

June 10, 2025
5 Ways Medicaid Supports Main Streets Across America
Health and Wellness

5 Ways Medicaid Supports Main Streets Across America

June 9, 2025
Secretary Of HHS Kennedy Fires Entire CDC’s Vaccine Advisory Committee
Health and Wellness

Secretary Of HHS Kennedy Fires Entire CDC’s Vaccine Advisory Committee

June 9, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?